These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27917818)

  • 1. Galectin-3: A biochemical marker to detect paroxysmal atrial fibrillation?
    Selcoki Y; Aydin Hİ; Celik TH; Isleyen A; Erayman A; Demircelik MB; Demirin H; Kosus A; Eryonucu B
    Clin Invest Med; 2016 Dec; 39(6):27528. PubMed ID: 27917818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of persistent atrial fibrillation on serum galectin-3 levels.
    Gurses KM; Yalcin MU; Kocyigit D; Canpinar H; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Ozer N; Tokgozoglu L; Oto MA; Guc D; Aytemir K
    Am J Cardiol; 2015 Mar; 115(5):647-51. PubMed ID: 25604929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling.
    Yalcin MU; Gurses KM; Kocyigit D; Canpinar H; Canpolat U; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Tokgozoglu L; Oto MA; Ozer N; Guc D; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):635-40. PubMed ID: 25684038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Galectin-3 in Patients With Paroxysmal and Persistent Atrial Fibrillation and Metabolic Syndrome].
    A VA; Zaslavskaya EL; Soboleva AV; Baranova EI; Listopad OV; Nifontov SE; Nrady AO; Shlyakhto EV
    Kardiologiia; 2016 Jun; 56(6):41-45. PubMed ID: 28290846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation.
    Begg GA; Karim R; Oesterlein T; Graham LN; Hogarth AJ; Page SP; Pepper CB; Rhode K; Lip GYH; Holden AV; Plein S; Tayebjee MH
    Europace; 2017 Dec; 19(12):1944-1950. PubMed ID: 28339804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Galectin-3 is Associated With Left Atrial Appendage Remodelling and Thrombus Formation in Patients With Atrial Fibrillation.
    Tang Z; Zeng L; Lin Y; Han Z; Gu J; Wang C; Zhang H
    Heart Lung Circ; 2019 Jun; 28(6):923-931. PubMed ID: 29861319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation.
    Berger WR; Jagu B; van den Berg NWE; Chan Pin Yin DRPP; van Straalen JP; de Boer OJ; Driessen AHG; Neefs J; Krul SPJ; van Boven WP; van der Wal AC; de Groot JR
    Europace; 2018 May; 20(5):764-771. PubMed ID: 28525549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis.
    Gong M; Cheung A; Wang QS; Li G; Goudis CA; Bazoukis G; Lip GYH; Baranchuk A; Korantzopoulos P; Letsas KP; Tse G; Liu T
    J Clin Lab Anal; 2020 Mar; 34(3):e23104. PubMed ID: 31917884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients.
    Gürses KM; Yalçın MU; Koçyiğit D; Canpınar H; Ateş AH; Canpolat U; Yorgun H; Güç D; Aytemir K
    Turk Kardiyol Dern Ars; 2019 Oct; 47(7):564-571. PubMed ID: 31582678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum galectin-3 level as a marker of thrombogenicity in atrial fibrillation.
    Kocyigit D; Gurses KM; Yalcin MU; Canpinar H; Canpolat U; Evranos B; Yorgun H; Ozer N; Guc D; Aytemir K
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28295609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome.
    Ionin VA; Baranova EI; Zaslavskaya EL; Petrishcheva EY; Morozov AN; Shlyakhto EV
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation.
    Hernández-Romero D; Vílchez JA; Lahoz Á; Romero-Aniorte AI; Jover E; García-Alberola A; Jara-Rubio R; Martínez CM; Valdés M; Marín F
    Sci Rep; 2017 Jan; 7():40378. PubMed ID: 28079145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation.
    Kornej J; Schmidl J; Ueberham L; John S; Daneschnejad S; Dinov B; Hindricks G; Adams V; Husser D; Bollmann A
    PLoS One; 2015; 10(4):e0123574. PubMed ID: 25875595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
    Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
    Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin 3 and incident atrial fibrillation in the community.
    Ho JE; Yin X; Levy D; Vasan RS; Magnani JW; Ellinor PT; McManus DD; Lubitz SA; Larson MG; Benjamin EJ
    Am Heart J; 2014 May; 167(5):729-34.e1. PubMed ID: 24766984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between vitamin D level and left atrial fibrosis in patients with lone paroxysmal atrial fibrillation undergoing cryoballoon-based catheter ablation.
    Canpolat U; Aytemir K; Hazirolan T; Özer N; Oto A
    J Cardiol; 2017 Jan; 69(1):16-23. PubMed ID: 27554047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum lysyl oxidase-like 2 levels correlate with the degree of left atrial fibrosis in patients with atrial fibrillation.
    Zhao Y; Tang K; Tianbao X; Wang J; Yang J; Li D
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29089463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 and atrial fibrillation.
    Duygu H
    Int J Cardiol; 2017 Feb; 229():1. PubMed ID: 27986283
    [No Abstract]   [Full Text] [Related]  

  • 19. M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation.
    Gurses KM; Yalcin MU; Kocyigit D; Kesikli SA; Canpolat U; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Ozer N; Oto MA; Guc D; Aytemir K
    Europace; 2015 Feb; 17(2):239-46. PubMed ID: 25238749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications.
    Clementy N; Piver E; Bisson A; Andre C; Bernard A; Pierre B; Fauchier L; Babuty D
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.